Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 527

1.

The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease.

Scheiner B, Northup PG, Gruber AB, Semmler G, Leitner G, Quehenberger P, Thaler J, Ay C, Trauner M, Reiberger T, Lisman T, Mandorfer M.

Liver Int. 2020 Feb 13. doi: 10.1111/liv.14404. [Epub ahead of print]

PMID:
32052552
2.

Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH.

Bruschi FV, Tardelli M, Herac M, Claudel T, Trauner M.

Liver Int. 2020 Feb 11. doi: 10.1111/liv.14402. [Epub ahead of print]

PMID:
32043752
3.

Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis.

Trauner M, Gindin Y, Jiang Z, Chung C, Subramanian GM, Myers RP, Gulamhusein A, Kowdley KV, Levy C, Goodman Z, Manns MP, Muir AJ, Bowlus CL.

JHEP Rep. 2019 Dec 5;2(1):100060. doi: 10.1016/j.jhepr.2019.11.004. eCollection 2020 Feb.

4.

HSD17B13 truncated variant is associated with a mild hepatic phenotype in Wilson's Disease.

Ferenci P, Pfeiffenberger J, Stättermayer AF, Stauber RE, Willheim C, Weiss KH, Munda-Steindl P, Trauner M, Schilsky M, Zoller H.

JHEP Rep. 2019 Mar 19;1(1):2-8. doi: 10.1016/j.jhepr.2019.02.007. eCollection 2019 May.

5.

Epidemiological trends in HCV transmission and prevalence in the Viennese HIV+ population.

Schmidbauer C, Chromy D, Schmidbauer V, Bauer D, Apata M, Nguyen D, Mandorfer M, Simbrunner B, Rieger A, Mayer F, Schmidt R, Holzmann H, Trauner M, Gschwantler M, Reiberger T.

Liver Int. 2020 Feb 4. doi: 10.1111/liv.14399. [Epub ahead of print]

PMID:
32017359
6.

FXR-dependent Rubicon induction impairs autophagy in models of human cholestasis.

Panzitt K, Jungwirth E, Krones E, Lee JM, Pollheimer M, Thallinger GG, Kolb-Lenz D, Xiao R, Thorell A, Trauner M, Fickert P, Marschall HU, Moore DD, Wagner M.

J Hepatol. 2020 Jan 27. pii: S0168-8278(20)30031-3. doi: 10.1016/j.jhep.2020.01.014. [Epub ahead of print]

7.

E2F-Family Members Engage the PIDDosome to Limit Hepatocyte Ploidy in Liver Development and Regeneration.

Sladky VC, Knapp K, Soratroi C, Heppke J, Eichin F, Rocamora-Reverte L, Szabo TG, Bongiovanni L, Westendorp B, Moreno E, van Liere EA, Bakker B, Spierings DCJ, Wardenaar R, Pereyra D, Starlinger P, Schultze S, Trauner M, Stojakovic T, Scharnagl H, Fava LL, Foijer F, de Bruin A, Villunger A.

Dev Cell. 2020 Feb 10;52(3):335-349.e7. doi: 10.1016/j.devcel.2019.12.016. Epub 2020 Jan 23.

PMID:
31983631
8.

Anemia and iron deficiency in compensated and decompensated cirrhosis: Prevalence and impact on clinical outcomes.

Paternostro R, Kapzan L, Mandorfer M, Schwarzer R, Schäfer B, Viveiros A, Bauer D, Ferlitsch M, Zoller H, Trauner M, Ferlitsch A.

J Gastroenterol Hepatol. 2020 Jan 23. doi: 10.1111/jgh.14988. [Epub ahead of print]

PMID:
31972057
9.

Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension.

Scheiner B, Stättermayer AF, Schwabl P, Bucsics T, Paternostro R, Bauer D, Simbrunner B, Schmidt R, Marculescu R, Ferlitsch A, Peck-Radosavljevic M, Pinter M, Trauner M, Reiberger T, Ferenci P, Mandorfer M.

Liver Int. 2020 Feb;40(2):393-404. doi: 10.1111/liv.14304. Epub 2019 Dec 3.

10.

Portal hypertensive gastropathy is associated with iron deficiency anemia.

Simbrunner B, Beer A, Wöran K, Schmitz F, Primas C, Wewalka M, Pinter M, Dolak W, Scheiner B, Puespoek A, Trauner M, Oberhuber G, Mandorfer M, Reiberger T.

Wien Klin Wochenschr. 2020 Jan;132(1-2):1-11. doi: 10.1007/s00508-019-01593-w. Epub 2020 Jan 7.

11.

Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson disease.

Paternostro R, Pfeiffenberger J, Ferenci P, Stättermayer AF, Stauber RE, Wrba F, Longerich T, Lackner K, Trauner M, Ferlitsch A, Reiberger T, Weiss KH.

Liver Int. 2020 Jan 2. doi: 10.1111/liv.14368. [Epub ahead of print]

PMID:
31898387
12.

Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.

Unger LW, Forstner B, Muckenhuber M, Scheuba K, Eigenbauer E, Scheiner B, Pfisterer N, Paternostro R, Trauner M, Mandorfer M, Reiberger T.

Dig Dis Sci. 2019 Dec 24. doi: 10.1007/s10620-019-06000-y. [Epub ahead of print]

PMID:
31875288
13.

The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.

Schwarzer R, Reiberger T, Mandorfer M, Kivaranovic D, Hametner S, Hametner S, Paternostro R, Scheiner B, Schneeweiss-Friedl J, Trauner M, Schoefl R, Maieron A.

J Gastroenterol. 2019 Dec 12. doi: 10.1007/s00535-019-01656-9. [Epub ahead of print]

PMID:
31832759
14.

Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects.

Smajis S, Gajdošík M, Pfleger L, Traussnigg S, Kienbacher C, Halilbasic E, Ranzenberger-Haider T, Stangl A, Beiglböck H, Wolf P, Lamp T, Hofer A, Gastaldelli A, Barbieri C, Luger A, Trattnig S, Kautzky-Willer A, Krššák M, Trauner M, Krebs M.

Am J Clin Nutr. 2020 Feb 1;111(2):369-377. doi: 10.1093/ajcn/nqz271.

PMID:
31796953
15.

Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function.

Lercher A, Bhattacharya A, Popa AM, Caldera M, Schlapansky MF, Baazim H, Agerer B, Gürtl B, Kosack L, Májek P, Brunner JS, Vitko D, Pinter T, Genger JW, Orlova A, Pikor N, Reil D, Ozsvár-Kozma M, Kalinke U, Ludewig B, Moriggl R, Bennett KL, Menche J, Cheng PN, Schabbauer G, Trauner M, Klavins K, Bergthaler A.

Immunity. 2019 Dec 17;51(6):1074-1087.e9. doi: 10.1016/j.immuni.2019.10.014. Epub 2019 Nov 26.

17.

Von Willebrand factor facilitates MELD-independent risk stratification on the waiting list for liver transplantation.

Györi GP, Pereyra D, Rumpf B, Hackl H, Köditz C, Ortmayr G, Reiberger T, Trauner M, Berlakovich GA, Starlinger P.

Hepatology. 2019 Nov 27. doi: 10.1002/hep.31047. [Epub ahead of print]

PMID:
31773739
18.

The impact of hepatic steatosis on portal hypertension.

Semmler G, Scheiner B, Schwabl P, Bucsics T, Paternostro R, Chromy D, Stättermayer AF, Trauner M, Mandorfer M, Ferlitsch A, Reiberger T.

PLoS One. 2019 Nov 6;14(11):e0224506. doi: 10.1371/journal.pone.0224506. eCollection 2019.

19.

Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.

Staufer K, Halilbasic E, Spindelboeck W, Eilenberg M, Prager G, Stadlbauer V, Posch A, Munda P, Marculescu R, Obermayer-Pietsch B, Stift J, Lackner C, Trauner M, Stauber RE.

United European Gastroenterol J. 2019 Oct;7(8):1113-1123. doi: 10.1177/2050640619865133. Epub 2019 Jul 12.

20.

Gut-liver axis signaling in portal hypertension.

Simbrunner B, Mandorfer M, Trauner M, Reiberger T.

World J Gastroenterol. 2019 Oct 21;25(39):5897-5917. doi: 10.3748/wjg.v25.i39.5897. Review.

21.

The challenges of primary biliary cholangitis: What is new and what needs to be done.

Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Vierling JM, Adams D, Alpini G, Banales JM, Beuers U, Björnsson E, Bowlus C, Carbone M, Chazouillères O, Dalekos G, De Gottardi A, Harada K, Hirschfield G, Invernizzi P, Jones D, Krawitt E, Lanzavecchia A, Lian ZX, Ma X, Manns M, Mavilio D, Quigley EM, Sallusto F, Shimoda S, Strazzabosco M, Swain M, Tanaka A, Trauner M, Tsuneyama K, Zigmond E, Gershwin ME.

J Autoimmun. 2019 Dec;105:102328. doi: 10.1016/j.jaut.2019.102328. Epub 2019 Sep 20. Review.

PMID:
31548157
22.

Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis.

Tardelli M, Bruschi FV, Fuchs CD, Claudel T, Auer N, Kunczer V, Baumgartner M, A H O Ronda O, Verkade HJ, Stojakovic T, Scharnagl H, Habib A, Zimmermann R, Lotersztajn S, Trauner M.

Hepatology. 2019 Sep 10. doi: 10.1002/hep.30929. [Epub ahead of print]

PMID:
31505038
23.

Impact of adenoma detection rate on detection of advanced adenomas and endoscopic adverse events in a study of over 200,000 screening colonoscopies.

Penz D, Ferlitsch A, Waldmann E, Irina G, Daniel P, Asaturi A, Hinterberger A, Majcher B, Szymanska A, Trauner M, Ferlitsch M.

Gastrointest Endosc. 2020 Jan;91(1):135-141. doi: 10.1016/j.gie.2019.08.038. Epub 2019 Sep 6.

PMID:
31499041
24.

PNPLA3 I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate Cells.

Bruschi FV, Claudel T, Tardelli M, Starlinger P, Marra F, Trauner M.

Hepatol Commun. 2019 Jul 15;3(9):1191-1204. doi: 10.1002/hep4.1395. eCollection 2019 Sep.

25.

Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver disease.

Unger LW, Forstner B, Schneglberger S, Muckenhuber M, Eigenbauer E, Scheiner B, Mandorfer M, Trauner M, Reiberger T.

Wien Klin Wochenschr. 2019 Sep;131(17-18):395-403. doi: 10.1007/s00508-019-01544-5. Epub 2019 Sep 6.

26.

Detection of Various Microplastics in Human Stool: A Prospective Case Series.

Schwabl P, Köppel S, Königshofer P, Bucsics T, Trauner M, Reiberger T, Liebmann B.

Ann Intern Med. 2019 Sep 3. doi: 10.7326/M19-0618. [Epub ahead of print]

PMID:
31476765
27.

Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl4 mouse model.

Reiter FP, Ye L, Bösch F, Wimmer R, Artmann R, Ziesch A, Kanitz V, Mayr D, Steib CJ, Trauner M, Regel I, Gerbes AL, Mayerle J, Hohenester S, de Toni EN, Denk G.

Lab Invest. 2019 Dec;99(12):1906-1917. doi: 10.1038/s41374-019-0310-1. Epub 2019 Aug 29.

PMID:
31467426
28.

Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease.

Scheiner B, Semmler G, Maurer F, Schwabl P, Bucsics TA, Paternostro R, Bauer D, Simbrunner B, Trauner M, Mandorfer M, Reiberger T.

Liver Int. 2020 Jan;40(1):194-204. doi: 10.1111/liv.14229. Epub 2019 Sep 13.

29.

The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis.

Paternostro R, Lampichler K, Bardach C, Asenbaum U, Landler C, Bauer D, Mandorfer M, Schwarzer R, Trauner M, Reiberger T, Ferlitsch A.

Liver Int. 2019 Dec;39(12):2374-2385. doi: 10.1111/liv.14217. Epub 2019 Sep 11.

30.

Guideline-conform statin use reduces overall mortality in patients with compensated liver disease.

Unger LW, Forstner B, Schneglberger S, Muckenhuber M, Eigenbauer E, Bauer D, Scheiner B, Mandorfer M, Trauner M, Reiberger T.

Sci Rep. 2019 Aug 12;9(1):11674. doi: 10.1038/s41598-019-47943-6.

31.

Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy.

Mandorfer M, Kozbial K, Schwabl P, Chromy D, Semmler G, Stättermayer AF, Pinter M, Hernández-Gea V, Fritzer-Szekeres M, Steindl-Munda P, Trauner M, Peck-Radosavljevic M, García-Pagán JC, Ferenci P, Reiberger T.

Hepatology. 2019 Jul 31. doi: 10.1002/hep.30885. [Epub ahead of print]

PMID:
31365764
32.

Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial.

Traussnigg S, Schattenberg JM, Demir M, Wiegand J, Geier A, Teuber G, Hofmann WP, Kremer AE, Spreda F, Kluwe J, Petersen J, Boettler T, Rainer F, Halilbasic E, Greinwald R, Pröls M, Manns MP, Fickert P, Trauner M; Austrian/German NAFLD-norUDCA study group.

Lancet Gastroenterol Hepatol. 2019 Oct;4(10):781-793. doi: 10.1016/S2468-1253(19)30184-0. Epub 2019 Jul 22.

PMID:
31345778
33.

Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma.

Scheiner B, Ulbrich G, Mandorfer M, Reiberger T, Müller C, Waneck F, Trauner M, Kölblinger C, Ferlitsch A, Sieghart W, Peck-Radosavljevic M, Pinter M.

United European Gastroenterol J. 2019 Jul;7(6):850-858. doi: 10.1177/2050640619840199. Epub 2019 Mar 21.

34.

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials.

Anstee QM, Lawitz EJ, Alkhouri N, Wong VW, Romero-Gomez M, Okanoue T, Trauner M, Kersey K, Li G, Han L, Jia C, Wang L, Chen G, Subramanian GM, Myers RP, Djedjos CS, Kohli A, Bzowej N, Younes Z, Sarin S, Shiffman ML, Harrison SA, Afdhal NH, Goodman Z, Younossi ZM.

Hepatology. 2019 Nov;70(5):1521-1530. doi: 10.1002/hep.30842. Epub 2019 Aug 19.

PMID:
31271665
35.

Obeticholic acid may increase the risk of gallstone formation in susceptible patients.

Al-Dury S, Wahlström A, Panzitt K, Thorell A, Ståhlman M, Trauner M, Fickert P, Bäckhed F, Fändriks L, Wagner M, Marschall HU.

J Hepatol. 2019 Nov;71(5):986-991. doi: 10.1016/j.jhep.2019.06.011. Epub 2019 Jun 27.

PMID:
31254596
36.

Liver Injury and Failure in Critical Illness.

Horvatits T, Drolz A, Trauner M, Fuhrmann V.

Hepatology. 2019 Dec;70(6):2204-2215. doi: 10.1002/hep.30824. Review.

PMID:
31215660
37.

Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites.

Simbrunner B, Röthenbacher A, Haslacher H, Bauer D, Chromy D, Bucsics T, Schwabl P, Paternostro R, Scheiner B, Trauner M, Mandorfer M, Schwarzinger I, Reiberger T.

United European Gastroenterol J. 2019 Jun;7(5):651-661. doi: 10.1177/2050640619843000. Epub 2019 Apr 5.

38.

Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension.

Semmler G, Stift J, Scheiner B, Wöran K, Schwabl P, Paternostro R, Bucsics T, Stättermayer AF, Pinter M, Ferlitsch A, Trauner M, Reiberger T, Mandorfer M.

Dig Dis Sci. 2019 Dec;64(12):3642-3651. doi: 10.1007/s10620-019-05702-7. Epub 2019 Jun 17.

39.

Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma.

Scheiner B, Kirstein M, Popp S, Hucke F, Bota S, Rohr-Udilova N, Reiberger T, Müller C, Trauner M, Peck-Radosavljevic M, Vogel A, Sieghart W, Pinter M.

Liver Cancer. 2019 May;8(3):203-217. doi: 10.1159/000489833. Epub 2018 Jun 22.

40.

C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation.

Meischl T, Rasoul-Rockenschaub S, Györi G, Sieghart W, Reiberger T, Trauner M, Soliman T, Berlakovich G, Pinter M.

PLoS One. 2019 May 29;14(5):e0216677. doi: 10.1371/journal.pone.0216677. eCollection 2019.

41.

Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.

Hamesch K, Mandorfer M, Pereira VM, Moeller LS, Pons M, Dolman GE, Reichert MC, Schneider CV, Woditsch V, Voss J, Lindhauer C, Fromme M, Spivak I, Guldiken N, Zhou B, Arslanow A, Schaefer B, Zoller H, Aigner E, Reiberger T, Wetzel M, Siegmund B, Simões C, Gaspar R, Maia L, Costa D, Bento-Miranda M, van Helden J, Yagmur E, Bzdok D, Stolk J, Gleiber W, Knipel V, Windisch W, Mahadeva R, Bals R, Koczulla R, Barrecheguren M, Miravitlles M, Janciauskiene S, Stickel F, Lammert F, Liberal R, Genesca J, Griffiths WJ, Trauner M, Krag A, Trautwein C, Strnad P; European Alpha1-Liver Study Group.

Gastroenterology. 2019 Sep;157(3):705-719.e18. doi: 10.1053/j.gastro.2019.05.013. Epub 2019 May 20.

PMID:
31121167
42.

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.

Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer AE, Vetter M, de Krijger M, Ponsioen CY, Trivedi P, Hirschfield G, Schramm C, Liu CH, Bowlus CL, Estes DJ, Pratt D, Hedin C, Bergquist A, de Vries AC, van der Woude CJ, Yu L, Assis DN, Boyer J, Ytting H, Hallibasic E, Trauner M, Marschall HU, Daretti LM, Marzioni M, Yimam KK, Perin N, Floreani A, Beretta-Piccoli BT, Rogers JK; International Primary Sclerosing Cholangitis Study Group (IPSCSG), Levy C.

Clin Gastroenterol Hepatol. 2020 Jan;18(1):179-187.e6. doi: 10.1016/j.cgh.2019.05.013. Epub 2019 May 14.

43.

Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication.

Chromy D, Mandorfer M, Bucsics T, Schwabl P, Bauer D, Scheiner B, Schmidbauer C, Lang GF, Szekeres T, Ferenci P, Trauner M, Reiberger T.

AIDS Patient Care STDS. 2019 May;33(5):197-206. doi: 10.1089/apc.2018.0333.

PMID:
31067123
44.

The zinc-finger transcription factor MAZR regulates iNKT cell subset differentiation.

Orola MJ, Tizian C, Zhu C, Andersen L, Gülich AF, Alteneder M, Stojakovic T, Wiedermann U, Trauner M, Ellmeier W, Sakaguchi S.

Cell Mol Life Sci. 2019 Nov;76(21):4391-4404. doi: 10.1007/s00018-019-03119-z. Epub 2019 May 7.

45.

High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patients.

Chromy D, Mandorfer M, Bucsics T, Schwabl P, Scheiner B, Schmidbauer C, Aichelburg MC, Ferenci P, Trauner M, Peck-Radosavljevic M, Reiberger T.

United European Gastroenterol J. 2019 May;7(4):507-516. doi: 10.1177/2050640619835394. Epub 2019 Mar 6.

46.

Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.

Semmler G, Simbrunner B, Scheiner B, Schwabl P, Paternostro R, Bucsics T, Stättermayer AF, Bauer D, Pinter M, Ferenci P, Trauner M, Mandorfer M, Reiberger T.

J Gastroenterol Hepatol. 2019 Dec;34(12):2164-2172. doi: 10.1111/jgh.14700. Epub 2019 Jun 14.

47.

Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption.

Tardelli M, Bruschi FV, Claudel T, Fuchs CD, Auer N, Kunczer V, Stojakovic T, Scharnagl H, Habib A, Grabner GF, Zimmermann R, Lotersztajn S, Trauner M.

J Lipid Res. 2019 Jul;60(7):1284-1292. doi: 10.1194/jlr.M093369. Epub 2019 May 2.

PMID:
31048404
48.

Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort.

Scheiner B, Kirstein MM, Hucke F, Finkelmeier F, Schulze K, von Felden J, Koch S, Schwabl P, Hinrichs JB, Waneck F, Waidmann O, Reiberger T, Müller C, Sieghart W, Trauner M, Weinmann A, Wege H, Trojan J, Peck-Radosavljevic M, Vogel A, Pinter M.

Aliment Pharmacol Ther. 2019 May;49(10):1323-1333. doi: 10.1111/apt.15245. Epub 2019 Apr 12.

49.

Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study.

Trauner M, Nevens F, Shiffman ML, Drenth JPH, Bowlus CL, Vargas V, Andreone P, Hirschfield GM, Pencek R, Malecha ES, MacConell L, Shapiro D.

Lancet Gastroenterol Hepatol. 2019 Jun;4(6):445-453. doi: 10.1016/S2468-1253(19)30094-9. Epub 2019 Mar 26.

PMID:
30922873
50.

MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.

Winhofer Y, Wolf P, Fellinger P, Tura A, Hillebrand P, Staufer K, Trauner M, Jaksch P, Muraközy G, Kautzky-Willer A, Pacini G, Krebs M, Luger A, Kazemi-Shirazi L.

Endocr Pract. 2019 Mar;25(3):254-262. doi: 10.4158/EP-2018-0461.

PMID:
30913015

Supplemental Content

Loading ...
Support Center